Vnitr Lek 2021, 67(3):e33-e34 | DOI: 10.36290/vnl.2021.049

Komentář k článku: Co může internista udělat pro svého pacienta po ischemické cévní mozkové příhodě Vnitř Lek 2021; 67(1): 7-14
Co může diabetolog udělat pro svého pacienta po iCMP?

Jan Brož1, Jana Malinovská1, Barbora Pelechová1, Jana Urbanová2, Ludmila Brunerová2
1 Interní klinika FN Motol a 2. LF UK, Praha
2 Interní klinika 3. LF UK a FNKV, Praha

Published: May 26, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brož J, Malinovská J, Pelechová B, Urbanová J, Brunerová L. Komentář k článku: Co může internista udělat pro svého pacienta po ischemické cévní mozkové příhodě Vnitř Lek 2021; 67(1): 7-14
Co může diabetolog udělat pro svého pacienta po iCMP? Vnitr Lek. 2021;67(3):e33-34. doi: 10.36290/vnl.2021.049.
Download citation

References

  1. Škorňa M. Co může internista udělat pro svého pacienta po iCMP? Vnitr Lek 2021; 67(1): 7-14. Go to original source... Go to PubMed...
  2. Emerging Risk Factors Collaboration: Sarwar N, Gao P, Seshasai SR et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222. Go to original source... Go to PubMed...
  3. Khoury JC, Kleindorfer D, Alwell K et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013; 44(6): 1500-1504. Go to original source... Go to PubMed...
  4. Reeves MJ, Vaidya RS, Fonarow GC, Liang L, Smith EE, Matulonis R, Olson DM, Schwamm LH; Get With The Guidelines Steering Committee and Hospitals: Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke. Stroke 2010; 41: e409-e417. Go to original source... Go to PubMed...
  5. Newman GC, Bang H, Hussain SI, Toole JF: Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology 2007; 69: 2054-2062. Go to original source... Go to PubMed...
  6. Kernan WN, Viscoli CM, Furie KL et al.; IRIS Trial Investigators: Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med; 374: 1321-1331. Go to original source... Go to PubMed...
  7. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86. Go to original source... Go to PubMed...
  8. Diabetes and Stroke. In: Cowie CC, Casagrande SS, Menke A, et al., Diabetes in America. Bethesda, 2018, 3rd edition.
  9. Doporučení pro diagnostiku a léčbu arteriální hypertenze České společnosti pro hypertenzi 2017. [cit. 2021-04-03]. Dostupné z WWW: http://www.hypertension.cz/sqlcache/widimsky-1-hypertenze-kv-prevence-2018.pdf.
  10. Česká společnost pro aterosklerózu. Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. [cit. 2021-04-03]. Dostupné z WWW: https://www.cskb.cz/wp-content/uploads/2019/12/Stanovisko-v%C3%BDboru-%C4%8Cesk%C3%A9-spole%C4%8Dnosti-pro-ateroskler%C3%B3zu-k-doporu%C4%8Den%C3%ADm-ESC_EAS-pro-diagnostiku-a-l%C3%A9%C4%8Dbu-dyslipidemi%C3%AD-z-roku-2019.pdf
  11. Task Force Members. 2019 European Society of Cardiology guidelines on diabetes, pre-diabetes,and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2020; 41, 255323.
  12. David S.H. Bell, Edison Goncalves. Stroke in the patient with diabetes (Part 2) - Prevention and the effects of glucose lowering therapies. Diabetes Research and Clinical Practice 2020; 164,108199. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.